BIO-TECHNE Corp — Director's Dealing 2023

Apr 4, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-03-03

Reporting Person: Bohnen Shane (SVP - General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	135	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$47.60	2026-08-07	Common Stock (8848)		Direct
Stock Option (right to buy)	$66.97	2027-08-05	Common Stock (8944)		Direct
Stock Option (right to buy)	$120.46	2028-08-06	Common Stock (3460)		Direct
Stock Option (right to buy)	$94.52	2029-08-15	Common Stock (3508)		Direct

Footnotes

F1: Options to purchase 2,212 shares vest on each of 8/7/20, 8/7/21, 8/7/22 and 8/7/23.

F2: Options to purchase 2,236 shares vest on each of 8/5/21, 8/5/22, 8/5/23 and 8/5/24.

F3: Options to purchase 865 shares vest on each of 8/6/22, 8/6/23, 8/6/24 and 8/6/25.

F4: Options to purchase 877 shares vest on each of 8/15/23, 8/15/24, 8/15/25 and 8/15/26.